Lonza
Ed Venegas serves as the Associate Director of Cell Therapy Manufacturing at Lonza since March 2021, bringing extensive experience in the biotechnology and pharmaceutical industries. Prior to this role, Ed held multiple positions at Genentech from February 2010 to February 2021, including Senior Manufacturing Manager and Drug Product Manufacturing Manager. Career beginnings involved roles at companies such as Zach Systems as an Analytical Development Chemist and at Introgen Therapeutics, Inc. as a Quality Control Coordinator. Ed’s foundational experience was gained at Tanox, Inc., where various quality control roles were fulfilled from August 2001 to February 2007. Ed holds a degree from Texas A&M University.
This person is not in any teams
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.